Clinical reference Biomarker Directory
Back to directory

TFRC

Emerging

TFRC/soluble transferrin receptor helps diagnose iron deficiency even when inflammation confounds standard iron studies.

Also known as sTfR soluble transferrin receptor CD71
In plain language

TFRC/soluble transferrin receptor is a blood test for iron deficiency that, unlike ferritin, isn't thrown off by inflammation — making it especially useful in patients who have both anemia and an inflammatory condition at the same time.

Biomarker & context

TFRC encodes the transferrin receptor (CD71), a cell-surface protein reflecting cellular iron demand, particularly high on developing red blood cells.

What it indicates

Soluble transferrin receptor (sTfR) rises in iron deficiency but, unlike ferritin, isn't affected by inflammation, making it especially useful for diagnosing iron deficiency in patients who also have a chronic inflammatory condition that would otherwise muddy standard iron studies.

Diagnosis & clinical testing

Measured via serum immunoassay; the sTfR/log ferritin ratio is sometimes used as a composite index to further improve diagnostic accuracy for iron deficiency in complex or inflammatory clinical settings.

Guiding treatment

Confirmed iron deficiency (via sTfR or standard iron studies) is treated with iron supplementation after identifying and addressing the underlying cause of iron loss or inadequate intake.

Clinical significance

Not affected by inflammation, unlike ferritin, making it valuable in complex or chronically inflamed patients.

References
  1. General hematology reference literature on soluble transferrin receptor in iron deficiency diagnosis, particularly with concurrent inflammation.